Based on recent data, Dyne Therapeutics, Inc. (DYN) shows an Average True Range (ATR) of 0.91 and an Enterprise Value of 1.93B. Its average trading volume over the past 3 months is 2.62M, indicating liquidity. These fundamental metrics provide insight into DYN's underlying financial health and market activity.
| ATR | 0.91 |
| Enterprise Value | 1.93B |
| Avg Vol (3 Months) | 2.62M |
| Avg Vol (10 Days) | 6.78M |
Dyne Therapeutics, Inc. (DYN) technical indicators as of September 15, 2026: the SMA 20 is -2.32%, SMA 50 at -8.75%, and SMA 200 at 7.7%. The RSI 14 value is 45.42, suggesting its current momentum. These technical analysis signals help assess DYN's price trends and potential future movements.
| SMA 20 | -2.32% |
| SMA 50 | -8.75% |
| SMA 200 | 7.7% |
| RSI 14 | 45.42 |
Dyne Therapeutics, Inc. (DYN) stock performance overview as of September 15, 2026: The 52-week high is $27.31 (currently -35.24% below), and the 52-week low is $11.92 (currently 154.56% above). Over the past year, DYN's performance is 12.25%, compared to the S&P 500's 0.16% change.
| 52-Week High | 27.31 |
| 52-Week High Chg | -35.24% |
| 52-Week Low | 11.92 |
| 52-Week Low Chg | +154.56% |
| S&P 500 52-Week Chg | 0.16% |
According to market data, Dyne Therapeutics, Inc. (DYN) stock's recent performance metrics show that over the last month, DYN is -12.28%, with a Year-to-Date (YTD) performance of -15.24%. Over the past year, the stock has seen a 12.25% change. These figures summarize DYN's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 20.91 | 26.94 | 27.31 | 27.31 | 27.31 | 27.31 |
| Low | 17 | 17 | 17 | 14.96 | 11.92 | 14 |
| Performance | -5.04% | -12.28% | +1.22% | +80.81% | +12.25% | -15.24% |
According to current financial data, DYN stock's P/E (TTM) ratio is -5.58, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for DYN, including P/S (N/A), P/B (4.38), and P/FCF (-6.95), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | DYN | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -5.58 | -1.25 | -194.38 | 32.59 |
| P/S (TTM) | N/A | 3.74 | 467.58 | 5.98 |
| P/B (TTM) | 4.38 | 1.38 | 15.57 | 5.6 |
| P/FCF (TTM) | -6.95 | -1.91 | -700.33 | 28.75 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep